Boardroom Alpha
Boardroom Alpha
SOLS · Current Report (Form 8-K) · Filed July 27, 2026

Solstice Advanced Materials Inc — Current Report (Form 8-K)

Form
8-K
Filed
July 27, 2026
Period
Jul 24, 2026
Ticker
SOLS
Accession
0001104659-26-086878
Boardroom Alpha · Filing insights

Solstice amended its credit agreement to permit a $4.685B bridge financing for the merger with Element Solutions.

About Solstice Advanced Materials Inc
Market cap
$8.9B
Board grade
B-
Sector
Basic Materials
CEO
David B Sewell
Last annual meeting: May 22, 2026 · View full Solstice Advanced Materials Inc profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT – July 24, 2026

(Date of earliest event reported)

 

SOLSTICE ADVANCED MATERIALS INC.

(Exact name of Registrant as specified in its Charter)

 

Delaware 001-42812 33-2919563
(State or other jurisdiction of
incorporation)
(Commission File Number) (I.R.S. Employer Identification
Number)

 

115 Tabor Road  
Morris Plains, New Jersey 07950
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (973) 370-8188

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   SOLS   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01 Entry Into a Material Definitive Agreement.

 

On July 24, 2026, Solstice Advanced Materials Inc. (the “Company”), the consenting lenders, and JPMorgan Chase Bank, N.A., as administrative agent, entered into an amendment (the “Amendment”) to the existing credit agreement, dated October 29, 2025, between the Company, the guarantors named therein, the lenders and issuing banks party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (as so amended, the “Credit Agreement”). The Amendment amends the terms of the credit facilities to allow, among other things, for the provision of $4.685 billion in bridge financing to the Company and certain other transactions in connection with that certain agreement and plan of merger, dated as of July 6, 2026, with, among others, Solar Merger Sub One Inc., a Delaware corporation and a wholly-owned subsidiary of the Company, Solar Merger Sub Two LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company, and Element Solutions Inc., a Delaware corporation.

 

The foregoing description of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
No.
  Description
10.1  First Amendment to Credit Agreement, dated as of July 24, 2026, among Solstice Advanced Materials Inc., the consenting lenders, and JPMorgan Chase Bank, N.A.
104  Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

# Schedules and/or exhibits have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 27, 2026 SOLSTICE ADVANCED MATERIALS INC.
     
    By: /s/ Brian Rudick
    Brian Rudick
   

Senior Vice President,

General Counsel & Corporate Secretary

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Solstice Advanced Materials Inc (SOLS)

Reference

Frequently asked questions

When did Solstice Advanced Materials Inc file this 8-K?
Solstice Advanced Materials Inc (SOLS) filed this Current Report (Form 8-K) with the SEC on July 27, 2026. The accession number assigned by EDGAR is 0001104659-26-086878.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Solstice amended its credit agreement to permit a $4.685B bridge financing for the merger with Element Solutions. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Solstice Advanced Materials Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Solstice Advanced Materials Inc has filed under CIK 2064953, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer